Internal Medicine, Endocrinology, Diabetes, & Metabolism · Champaign, IL
NPI
1063895746
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1801 W Windsor Rd
Champaign, IL, 61822
Phone (217) 366-1372
Groups this clinician bills Medicare through
Medicare paid, 2024
$433K
32,738 services
Medicare patients, 2024
451
Average age 72
Drug cost, 2024
$4.8M
4,926 prescriptions
Company payments, 2025
$2,769
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yasser A Haider was code J3111 (injection, romosozumab-aqqg, 1 mg), 22,890 times for 26 patients. In total Yasser A Haider billed 32,738 services in 57 codes, and Medicare paid $433K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 22,890 | 26 | $8.54 | $196K |
| J0897 Injection, denosumab, 1 mg | Office | 5,520 | 59 | $20.50 | $113K |
| 36415 Venipuncture Blood Collection | Office | 587 | 327 | $8.58 | $5,037 |
| 99214 Office E&M - Established | Office | 582 | 345 | $85.29 | $50K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 551 | 342 | $11.50 | $6,337 |
| 83036 Blood Count | Office | 283 | 156 | $9.49 | $2,686 |
| 84443 Clinical Chemistry | Office | 236 | 152 | $16.33 | $3,854 |
| 96372 Injection Administration | Office | 225 | 80 | $10.38 | $2,337 |
| 80053 Clinical Chemistry | Office | 216 | 154 | $10.32 | $2,230 |
| 99215 Office E&M - Established | Office | 190 | 153 | $129.72 | $25K |
| 82306 Clinical Chemistry | Office | 147 | 115 | $28.94 | $4,253 |
| 84439 Clinical Chemistry | Office | 147 | 88 | $8.78 | $1,290 |
| 95251 Test - Miscellaneous | Office | 131 | 81 | $23.73 | $3,109 |
| 83970 Clinical Chemistry | Office | 126 | 90 | $40.45 | $5,097 |
| 82043 Clinical Chemistry | Office | 122 | 96 | $5.63 | $687 |
By year: 2022 $335K for 26,449 services; 2023 $384K for 28,492 services; 2024 $433K for 32,738 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 587 | 327 | $8.58 | $5,037 |
| 83036 Blood Count | 283 | 156 | $9.49 | $2,686 |
| 84443 Clinical Chemistry | 236 | 152 | $16.33 | $3,854 |
| 80053 Clinical Chemistry | 216 | 154 | $10.32 | $2,230 |
| 84439 Clinical Chemistry | 147 | 88 | $8.78 | $1,290 |
| 82306 Clinical Chemistry | 147 | 115 | $28.94 | $4,253 |
| 83970 Clinical Chemistry | 126 | 90 | $40.45 | $5,097 |
| 82570 Clinical Chemistry | 122 | 96 | $5.06 | $617 |
| 82043 Clinical Chemistry | 122 | 96 | $5.63 | $687 |
| 84481 Clinical Chemistry | 108 | 72 | $16.55 | $1,787 |
Medicare prescription drug claims, 2024
In 2024, the drug Yasser A Haider prescribed most often to Medicare patients was Levothyroxine Sodium, with 489 prescriptions and refills. In total Yasser A Haider wrote 4,926 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 489 | 1,337 | 155 | $5,841 |
| Ozempic Semaglutide | 427 | 842 | 136 | $778K |
| Jardiance Empagliflozin | 333 | 769 | 101 | $438K |
| Trulicity Dulaglutide | 202 | 320 | 56 | $305K |
| Metformin Hcl Er Metformin Hcl | 200 | 552 | 70 | $2,880 |
| Metformin Hcl Generic | 194 | 503 | 70 | $1,918 |
| Mounjaro Tirzepatide | 168 | 246 | 52 | $257K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 141 | 374 | 62 | $25K |
| Novolog Flexpen Insulin Aspart | 119 | 255 | 60 | $36K |
| Methimazole Generic | 111 | 278 | 32 | $1,418 |
| Pioglitazone Hcl Generic | 110 | 275 | 35 | $1,677 |
| Novolog Insulin Aspart | 110 | 249 | 35 | $37K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 109 | 265 | 46 | $59K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 109 | 207 | 32 | $146K |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 108 | 224 | 31 | $154K |
Brand drugs: 2,801 claims; generic drugs: 1,554 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yasser A Haider $2,769 ($2,769 in general payments such as food, travel and fees) from 29 companies. The largest payer was Insulet Corporation with $782.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 30 | $782 |
| Amgen Inc. AMGN | 28 | $464 |
| Lilly USA, LLC LLY | 11 | $202 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $146 |
| Xeris Pharmaceuticals, Inc. | 10 | $141 |
| Sequel Med Tech, LLC | 5 | $112 |
| Recordati_rare_diseases_inc. | 4 | $94.63 |
| Corcept Therapeutics CORT | 4 | $89.02 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $88.04 |
| Kyowa Kirin, Inc. 4151.T | 3 | $60.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.